Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 301–400 of 1,008
Neurodegeneration and demyelination in multiple sclerosis
Garton, T. P., Gadani, S. P., Gill, A. J., & Calabresi, P. A. (2024) · Neuron · doi:10.1016/j.neuron.2024.05.025 · Cited by 144
IgG glycan patterns are associated with type 2 diabetes in independent European populations
Lemmers, R. F. H., Vilaj, M. Ć., Urda, D., Agakov, F. V., Šimurina, M., Klarić, L., Rudan, I., Campbell, H. J., Hayward, C., Wilson, J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.06.020 · Cited by 135
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models
Sharma, S. K., Chow, A. T., Monette, S., Vivier, D., Pourat, J., Edwards, K. J., Dilling, T. R., Abdel-Atti, D., Zeglis, B. M., Poirier, J. T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1958 · Cited by 129
IgG and Fcγ Receptors in Intestinal Immunity and Inflammation
Castro‐Dopico, T., & Clatworthy, M. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00805 · Cited by 144
“With pleiotropic roles in immunity, detrimental IgG-driven immune responses are associated with several inflammatory and autoimmune disorders, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) (17, 18), but IgG antibodies are also key effector molecules that contribute to anti-microbial immuni…”
BackgroundGorman, M. J., Patel, N., Guebre-Xabier, M., Zhu, A. L., Atyeo, C., Pullen, K. M., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100405 · Cited by 129
Antibody Glycosylation and Inflammation
Shade, K.-T., & Anthony, R. M. (2013) · Antibodies · doi:10.3390/antib2030392 · Cited by 143
“Many immune cells including macrophages, dendritic cells, neutrophils express both activating and inhibitory FcγRs, the eventual signal elicited by IgG is governed by the affinity of IgG subclasses to distinct FcγRs (Kd = 10–10 M) and the combination of expression level and pattern of FcγRs [13–15].”
Backgroundvon Bredow, B., Arias, J. F., Heyer, L. N., Moldt, B., Le, K. M., Robinson, J. E., Zolla‐Pazner, S., Burton, D. R., & Evans, D. T. (2016) · Journal of Virology · doi:10.1128/jvi.00347-16 · Cited by 135
Andersen, M. N., Al‐Karradi, S. N. H., Kragstrup, T. W., & Hokland, M. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22995 · Cited by 121
Lefaucheur, C., Viglietti, D., Hidalgo, L. G., Ratner, L. E., Bagnasco, S. M., Batal, I., Aubert, O., Orandi, B. J., Oppenheimer, F., Bestard, O., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017050589 · Cited by 128
Morris, A. B., Farley, C. R., Pinelli, D. F., Adams, L. E., Cragg, M. S., Boss, J. M., Scharer, C. D., Fribourg, M., Cravedi, P., Heeger, P. S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.006 · Cited by 118
“These studies challenge long-held dogma that T cells do not express Fc receptors (Nimmerjahn and Ravetch, 2008).”
BackgroundLinnartz, B., & Neumann, H. (2013) · Glia · doi:10.1002/glia.22359 · Cited by 116
“The type I transmembrane glycoproteins Fcg receptors belong to the immunoglobulin superfamily (Nimmerjahn and Ravetch, 2008).”
BackgroundInfluentialNMR Characterization of Immunoglobulin G Fc Glycan Motion on Enzymatic Sialylation
Barb, A. W., Meng, L., Gao, Z., Johnson, R. W., Moremen, K. W., & Prestegard, J. H. (2012) · Biochemistry · doi:10.1021/bi300319q · Cited by 117
Alpert, M. D., Heyer, L. N., Williams, D. E. J., Harvey, J. D., Greenough, T. C., Allhorn, M., & Evans, D. T. (2012) · Journal of Virology · doi:10.1128/jvi.01650-12 · Cited by 130
Alquisiras-Burgos, I., Peralta-Arrieta, I., Alonso-Palomares, L. A., Zacapala-Gómez, A. E., Salmerón-Bárcenas, E. G., & Aguilera, P. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02134-7 · Cited by 115
Bodelón, G., Palomino, C., & Fernández, L. Á. (2013) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00347.x · Cited by 117
“To exert these effector functions the glycosylated Fc region interacts with blood serum proteins (e.g. C1q) and specific Fcc receptors (FccRs) found in immune cells (e.g. Natural Killer, Macrophages; Carroll, 2008; Nimmerjahn & Ravetch, 2008).”
BackgroundDC-STAMP: A Key Regulator in Osteoclast Differentiation: DC-STAMP: AN OSTEO-IMMUNOLOGICAL REGULATOR
Chiu, Y.-H., & Ritchlin, C. T. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25389 · Cited by 115
“Based on a common counter action between the ITAM- and ITIM-bearing receptors in immune regulation (Nimmerjahn and Ravetch, 2007, 2008), DC-STAMP is likely to participate in the network of RANKITAM costimulation.”
BackgroundStracke, J., Emrich, T., Rueger, P., Schlothauer, T., Kling, L., Knaupp, A., Hertenberger, H., Wolfert, A., Spick, C., Lau, W., et al. (2014) · mAbs · doi:10.4161/mabs.29601 · Cited by 112
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions
Abdeldaim, D. T., & Schindowski, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102402 · Cited by 129
Therapeutic Antibodies against Intracellular Tumor Antigens
Trenevska, I., Li, D., & Banham, A. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01001 · Cited by 118
B-cell targeted therapeutics in clinical development
Blüml, S., McKeever, K., Ettinger, R., Smolen, J., & Herbst, R. (2013) · Arthritis Research & Therapy · doi:10.1186/ar3906 · Cited by 110
“Th e most relevant activating FcγRs in human are FcγRIIA and FcγRIIIA [37,38].”
BackgroundInfluentialM2-based influenza vaccines: recent advances and clinical potential
Kolpe, A. B., Schepens, B., Fiers, W. C., & Saelens, X. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1240041 · Cited by 112
Shukla, S., Myers, J., Woods, S. E., Gong, X., Czapar, A. E., Commandeur, U., Huang, A. Y.-C., Levine, A. D., & Steinmetz, N. F. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.030 · Cited by 115
Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention
Li, Z., Yang, L., Li, L., Ye, Z., & Gong, W. (2024) · MedComm · doi:10.1002/mco2.419 · Cited by 144
“83 FcR includes FcRI (CD64), FcRII (CD32), and FcRIII (CD16), each with different intracellular motifs (ITAM or ITIM) that divide the receptors into inhibitory and activating types.”
BackgroundÅgerstam, H., Karlsson, C., Hansen, N., Sandén, C., Askmyr, M., von Palffy, S., Högberg, C., Rissler, M., Wunderlich, M., Juliusson, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422749112 · Cited by 111
Extending human IgG half-life using structure-guided design
Booth, B. J., Ramakrishnan, B., Narayan, K., Wollacott, A. M., Babcock, G. J., Shriver, Z., & Viswanathan, K. (2018) · mAbs · doi:10.1080/19420862.2018.1490119 · Cited by 107
Kaplonek, P., Fischinger, S., Cizmeci, D., Bartsch, Y. C., Kang, J., Burke, J. S., Shin, S. A., Dayal, D., Martin, P., Mann, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.001 · Cited by 121
Glycosylation and Fc Receptors
Hayes, J. M., Cosgrave, E. F. J., Struwe, W. B., Wormald, M., Davey, G. P., Jefferis, R., & Rudd, P. M. (2014) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-07911-0_8 · Cited by 110
“Two isoforms of FccRIIb, referred to as FccRIIb-1 and FccRIIb-2, exist as a result of alternative splicing and are expressed differentially depending on the cell type, FccRIIb-1 is exclusively expressed on B-cells and FccRIIb-2 is expressed on all other FccR cell types, except NK cells (Nimmerjahn and Ravetch 2008).”
BackgroundEffects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Leabman, M. K., Meng, Y. G., Kelley, R. F., DeForge, L. E., Cowan, K. J., & Iyer, S. (2013) · mAbs · doi:10.4161/mabs.26436 · Cited by 110
Phenotypic Variation in IgG Receptors by Nonclassical FCGR2C Alleles
van der Heijden, J., Breunis, W. B., Geissler, J., de Boer, M., van den Berg, T. K., & Kuijpers, T. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003945 · Cited by 110
“The balance between activating and inhibitory signals from the different receptor subtypes ensures control over immune complex-driven inflammatory responses (1).”
BackgroundIntravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease: Rationale and Current Evidence
Dodel, R. C., Neff, F., Noelker, C., Pul, R., Du, Y., Bacher, M., & Oertel, W. H. (2010) · Drugs · doi:10.2165/11533070-000000000-00000 · Cited by 125
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Li, S. S., Gilbert, P. B., Tomaras, G. D., Kijak, G. H., Ferrari, G., Thomas, R., Pyo, C., Zolla‐Pazner, S., Montefiori, D. C., Liao, H., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75539 · Cited by 117
Wu, J., Mishra, H. K., & Walcheck, B. K. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr1218-501r · Cited by 121
Qin, L., Zhang, H., Zhou, Y., Umeshappa, C. S., & Gao, H. (2021) · Small · doi:10.1002/smll.202006000 · Cited by 115
Jegerlehner, A., Wiesel, M., Dietmeier, K., Zabel, F., Gatto, D., Saudan, P., & Bachmann, M. F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.103 · Cited by 117
Li, F., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319502110 · Cited by 110
Self-citationKotsiliti, E., Leone, V., Schuehle, S., Govaere, O., Li, H., Wolf, M. J., Horvatic, H., Bierwirth, S., Hundertmark, J., Inverso, D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.037 · Cited by 108
TRIM 21: a cytosolic Fc receptor with broad antibody isotype specificity
Foss, S., Watkinson, R., Sandlie, I., James, L. C., & Andersen, J. T. (2015) · Immunological Reviews · doi:10.1111/imr.12363 · Cited by 126
“While extracellular detection of antibody-virus immune complexes by cell-surface-expressed FccRs results in phosphorylation of their intracellular immunoreceptor tyrosinebased activation motif, triggering phagocytosis and immune activation (8) , known mechanisms for detection of pathogens in the intracellular environm…”
BackgroundInfluentialMehlhop, E., Nelson, S., Jost, C. A., Gorlatov, S. N., Johnson, S., Fremont, D. H., Diamond, M., & Pierson, T. C. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.09.003 · Cited by 118
“…promote viral clearance and protection from disease in vivo often extend beyond their capacity to directly neutralize virus infectivity, and include effector mechanisms mediated by the crystallizable fragment (Fc) portion of the antibody molecule (Burton, 2002; Nimmerjahn and Ravetch, 2008).”
Noncanonical autophagy: one small step for LC3, one giant leap for immunity
Mehta, P., Hénault, J., Kolbeck, R., & Sanjuán, M. A. F. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.10.012 · Cited by 115
IgG4 Characteristics and Functions in Cancer Immunity
Crescioli, S., Corrêa, I., Karagiannis, P., Davies, A. M., Sutton, B. J., Nestle, F. O., & Karagiannis, S. N. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0580-7 · Cited by 119
Khanna, S., Thomas, A., Abate‐Daga, D., Zhang, J., Morrow, B., Steinberg, S. M., Orlandi, A., Ferroni, P., Schlom, J., Guadagni, F., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.07.033 · Cited by 111
B cell checkpoints in autoimmune rheumatic diseases
Rubin, S. J. S., Bloom, M. S., & Robinson, W. H. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0211-0 · Cited by 119
Tolerance induction with T cell–dependent protein antigens induces regulatory sialylated IgGs
Oefner, C. M., Winkler, A., Heß, C., Lorenz, A. K., Holecska, V., Huxdorf, M., Schommartz, T., Petzold, D., Bitterling, J., Schoen, A.-L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.037 · Cited by 120
Li, F., & Ravetch, J. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208698109 · Cited by 111
Self-citationSmalls-Mantey, A., Doria‐Rose, N. A., Klein, R. M., Patamawenu, A. A., Migueles, S. A., Ko, S., Hallahan, C. W., Wong, H. C., Liu, B., You, L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00287-12 · Cited by 128
Weber, F., Bohrmann, B., Niewoehner, J., Fischer, J. A. A., Rueger, P., Tiefenthaler, G., Moelleken, J., Bujotzek, A., Brady, K., Singer, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.019 · Cited by 104
STIM1 is essential for Fcγ receptor activation and autoimmune inflammation
Braun, A., Gessner, J. E., Varga-Szabó, D., Syed, S. N., Konrad, S., Stegner, D., Vögtle, T., Schmidt, R. E., & Nieswandt, B. (2008) · Blood · doi:10.1182/blood-2008-05-158477 · Cited by 106
Manish, M., Rahi, A., Kaur, M., Bhatnagar, R., & Singh, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061885 · Cited by 108
“The importance of Fcc receptors as the regulators of the protective immune response has been extensively established [47].”
BackgroundSimard, J.-C., Simon, M.-M., Tessier, P. A., & Girard, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002956 · Cited by 106
“Phagocytosis occurs through direct binding of bacteria and is facilitated by opsonization with Ig (2) or complement components (3).”
BackgroundFrom CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement
Coënon, L., & Villalba, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.913215 · Cited by 114
“Only CD64 is defined as a high-affinity receptor, while CD32b is the only inhibitory receptor (2, 3).”
BackgroundNeonatal tolerance under breastfeeding influence
Verhasselt, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.008 · Cited by 115
“The high ratio of IgG/antigen of milk borne immune complexes [14 ] as well as milk antibodies glycosylation might be responsible for these tolerogenic properties [80– 82].”
BackgroundExocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions
Baudhuin, J., Migraine, J., Faivre, V., Loumagne, L., Lukaszewicz, A.-C., Payen, D., & Favier, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221535110 · Cited by 102
Lilienthal, G., Rahmöller, J., Petry, J., Bartsch, Y. C., Leliavski, A., & Ehlers, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00958 · Cited by 115
Waight, J. D., Chand, D., Dietrich, S., Gombos, R., Horn, T., Gonzalez, A. M., Manrique, M., Swiech, L., Morin, B., Brittsan, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.005 · Cited by 104
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Steffen, U., Schett, G. A., & Bözec, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01483 · Cited by 111
Chen, Y., Pei, Y., Luo, J., Huang, Z., Yu, J., & Meng, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01088 · Cited by 116
IgG2m4, an engineered antibody isotype with reduced Fc function
An, Z., Forrest, G., Moore, R., Cukan, M., Haytko, P., Huang, L., Vitelli, S., Zhao, J. Z., Lu, P., Hua, J., et al. (2009) · mAbs · doi:10.4161/mabs.1.6.10185 · Cited by 102
Sundling, C., Forsell, M. N. E., O'Dell, S. J., Feng, Y., Chakrabarti, B. K., Rao, S. S., Loré, K., Mascola, J. R., Wyatt, R. T., Douagi, I., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100025 · Cited by 103
“A better understanding of the role for Ab isotypes relative to antibody neutralization and protection against infection is an important issue yet to be clarified (Liu et al., 2003; Huber and Trkola, 2007; Nimmerjahn and Ravetch, 2008).”
BackgroundOuyang, F., Wu, R., Yuan, W., Liu, R., Yang, D., Xiao, C., Zheng, L., Li, B., Lao, X., & Kuang, D. (2016) · Nature Communications · doi:10.1038/ncomms13453 · Cited by 109
Ishiwatari-Ogata, C., Kyuuma, M., Ogata, H., Yamakawa, M., Iwata, K., Ochi, M., Hori, M., Miyata, N., & Fujii, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.853008 · Cited by 107
Fcγ receptors: genetic variation, function, and disease
Hargreaves, C. E., Rose-Zerilli, M. J. J., Machado, L. R., Iriyama, C., Hollox, E. J., Cragg, M. S., & Strefford, J. C. (2015) · Immunological Reviews · doi:10.1111/imr.12341 · Cited by 113
Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors
Singh, R., Masuda, E. S., & Payan, D. G. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201271b · Cited by 106
Kawasaki Disease: The Role of Immune Complexes Revisited
Menikou, S., Langford, P. R., & Levin, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01156 · Cited by 103
Brezski, R. J., Vafa, O., Petrone, D., Tam, S. H., Powers, G. D., Ryan, M. H., Luongo, J. L., Greenplate, A. R., Knight, D. M., & Jordan, R. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904174106 · Cited by 105
Molecularly Defined Antibody Conjugation through a Selenocysteine Interface
Höfer, T., Skeffington, L. R., Chapman, C. M., & Rader, C. M. (2009) · Biochemistry · doi:10.1021/bi901744t · Cited by 104
Sloan, D. D., Lam, C. K., Irrinki, A., Liu, L., Tsai, A., Pace, C. S., Kaur, J., Murry, J. P., Balakrishnan, M., Moore, P. A., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005233 · Cited by 110
Antibody orientation at bacterial surfaces is related to invasive infection
Nordenfelt, P., Waldemarson, S., Linder, A., Mörgelin, M., Karlsson, C. A. Q., Malmström, J. A., & Björck, L. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120325 · Cited by 100
“…and complement to bacterial surfaces The IgG subclasses have different roles in the human im mune response, where IgG1 and IgG3 are the most impor tant for activating the complement system (Brüggemann et al., 1987), as well as triggering Fcmediated phagocytosis (Nimmerjahn and Ravetch, 2008).”
BackgroundImmunoreceptors on neutrophils
van Rees, D. J., Szilagyi, K., Kuijpers, T. W., Matlung, H. L., & van den Berg, T. K. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.02.004 · Cited by 114
“Fc␥R are receptors for the Fc portions of (aggregated) IgG, and therefore play a prominent role in the uptake of IgG-opsonized pathogens and perhaps host particles as well, and in the initiation of ADCC [80, 81] .”
BackgroundChiu, Y. G., Mensah, K. A., Schwarz, E. M., Ju, Y., Takahata, M., Feng, C., McMahon, L. A., Hicks, D. G., Panepento, B., Keng, P. C., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.531 · Cited by 108
Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita
Ludwig, R. J. (2013) · ISRN Dermatology · doi:10.1155/2013/812029 · Cited by 104
“FcgRIIB is the only so far described inhibitory FcgR in mice [177].”
BackgroundAntigen Cross-Presentation of Immune Complexes
Platzer, B., Stout, M., & Fiebiger, E. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00140 · Cited by 108
Holtsberg, F. W., Shulenin, S., Vu, H., Howell, K. A., Patel, S. J., Gunn, B. M., Karim, M. M., Lai, J. R., Frei, J. C., Nyakatura, E. K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02171-15 · Cited by 100
Activation and regulation of alloreactive T cell immunity in solid organ transplantation
Duneton, C., Winterberg, P. D., & Ford, M. L. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00600-0 · Cited by 112
Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay
Parekh, B. S., Berger, E., Sibley, S., Cahya, S., Liqun, X., LaCerte, M. A., Vaillancourt, P., Wooden, S. K., & Gately, D. P. (2012) · mAbs · doi:10.4161/mabs.19873 · Cited by 113
Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab
Kurdi, A. T., Glavey, S. V., Bezman, N. A., Jhatakia, A., Guerriero, J. L., Manier, S., Moschetta, M., Mishima, Y., Roccaro, A., Detappe, A., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0998 · Cited by 97
Liclican, A. C., Serafini, L., Xing, W., Czerwieniec, G. A., Steiner, B. H., Wang, T., Brendza, K. M., Lutz, J. D., Keegan, K. S., Ray, A. S., et al. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129531 · Cited by 101
Dopamine Receptor-Mediated Binding and Cellular Uptake of Polydopamine-Coated Nanoparticles
Liu, Y., Choi, C. K. K., Hong, H., Xiao, Y., Kwok, M. L., Liu, H., Tian, X. Y., & Choi, C. H. J. (2021) · ACS Nano · doi:10.1021/acsnano.1c06081 · Cited by 99
Forthal, D. N. (2015) · ASM Press eBooks · doi:10.1128/9781555817411.ch2 · Cited by 102
Siegers, G. M., Dhamko, H., Wang, X.-H., Mathieson, A. M., Kosaka, Y., Felizardo, T. C., Medin, J. A., Tohda, S., Schüler, J. B., Fisch, P., et al. (2011) · Cytotherapy · doi:10.3109/14653249.2011.553595 · Cited by 98
Esmail, H., Lai, R., Lesosky, M., Wilkinson, K. A., Graham, C. M., Horswell, S. D., Coussens, A. K., Barry, C. E., O’Garra, A., & Wilkinson, R. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711853115 · Cited by 110
Hawkins, P. T., Stephens, L., Suire, S., & Wilson, M. I. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_40 · Cited by 114
“SHIP1 is recruited through its SH2 domain to phosphotyrosines in the ITIM-motifs in the cytoplasmic tails of so-called inhibitory receptors, such as FcgRIIB (Nimmerjahn and Ravetch 2008).”
BackgroundBypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
Jung, S. T., Kang, T. H., Kelton, W., & Georgiou, G. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.03.002 · Cited by 99
Glycosylation of Immunoglobulin G: Role of Genetic and Epigenetic Influences
Menni, C., Keser, T., Mangino, M., Bell, J. T., Erte, I., Akmačić, I., Vučković, F., Pučić Baković, M., Gornik, O., McCarthy, M. I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082558 · Cited by 100
“Fine details of IgG glycan structure significantly affect function of immunoglobulins [21], thus close regulation of IgG glycosylation is required for proper function of the immune system [22].”
BackgroundIgG Glycan Hydrolysis Attenuates ANCA-Mediated Glomerulonephritis
van Timmeren, M. M., van der Veen, B. S., Stegeman, C. A., Petersen, A. H., Hellmark, T., Collin, M., & Heeringa, P. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090984 · Cited by 97
Custodio, A., & Feliú, J. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.05.001 · Cited by 110
Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions
James, L. K., & Till, S. J. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0600-2 · Cited by 110
Kurogochi, M., Mori, M., Osumi, K., Tojino, M., Sugawara, S.-I., Takashima, S., Hirose, Y., Tsukimura, W., Mizuno, M., Amano, J., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132848 · Cited by 96
“The terminal Gal residue is known to enhance CDC activity by increasing the binding of antibodies to C1q [15].”
BackgroundInfluentialZhang, J., He, Q., An, C., Mao, Q., Gao, F., Bian, L., Xing, W., Wang, Q., Liu, P., Song, L., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1957401 · Cited by 100
ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils
Wang, Y., Wu, J., Newton, R., Bahaie, N. S., Long, C., & Walcheck, B. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.11.027 · Cited by 97
“Unlike humans, only one gene encodes for CD16 in the mouse, and this is expressed as a transmembrane protein with an extracellular region highly homologous to mouse FcγRIIB [38].”
BackgroundSingle-Domain Antibodies and Their Formatting to Combat Viral Infections
Vlieger, D. D., Ballegeer, M., Rossey, I., Schepens, B., & Saelens, X. (2018) · Antibodies · doi:10.3390/antib8010001 · Cited by 96
“These effector functions include antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cell-mediated phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC); mechanisms that can eliminate infected cells or virions [60].”
BackgroundUse of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
Hossain, M. K., & Wall, K. A. (2019) · Cancers · doi:10.3390/cancers11030418 · Cited by 97
Zheng, C., Wang, Q., Wang, Y., Zhao, X., Gao, K., Liu, Q., Zhao, Y., Zhang, Z., Zheng, Y., Cao, J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902542 · Cited by 96
Nagelkerke, S. Q., Schmidt, D. E., de Haas, M., & Kuijpers, T. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02237 · Cited by 94
Puro, R. J., Bouchlaka, M. N., Hiebsch, R. R., Capoccia, B. J., Donio, M. J., Manning, P. T., Frazier, W. A., Karr, R. W., & Pereira, D. S. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-1079 · Cited by 100
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
Dixon, K. J., Wu, J., & Walcheck, B. K. (2021) · Cancers · doi:10.3390/cancers13020312 · Cited by 101
Jensen, P. F., Larraillet, V., Schlothauer, T., Kettenberger, H., Hilger, M., & Rand, K. D. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.042044 · Cited by 94
“The Fc region is composed of additional constant domains of the heavy chain (CH2 and CH3); it mediates antibody-dependent cellular cytotoxicity through interaction with Fc receptors (3, 4) and activates complement-dependent cytotoxicity through interaction with C1q (5).”
BackgroundChu, S. Y., Horton, H. M., Pong, E., Leung, I., Chen, H., Nguyen, D.-H. T., Bautista, C., Muchhal, U. S., Bernett, M. J., Moore, G. L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.029 · Cited by 94
Essential and unique roles of PIP5K-γ and -α in Fcγ receptor-mediated phagocytosis
Mao, Y. S., Yamaga, M., Zhu, X., Wei, Y., Sun, H.-Q., Wang, J., Yun, M., Wang, Y., Di Paolo, G., Bennett, M., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806121 · Cited by 96
“Error bars indicate SEM. n.s., not signifi cant. on A ugust 17, 2017 jcb.rupress.org D ow nloaded from 283PIP5KS IN PHAGOCYTOSIS • Mao et al. (ITAM) ( Nimmerjahn and Ravetch, 2008 ), oligomerizes to form microclusters ( Sobota et al., 2005 ).”
BackgroundMethodInfluentialvon Kietzell, K., Pozzuto, T., Heilbronn, R., Größl, T., Fechner, H., & Weger, S. (2014) · Journal of Virology · doi:10.1128/jvi.00649-14 · Cited by 103
Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
Zhang, N., Liu, L., Dumitru, C. D., Houston-Cummings, N. R., Cukan, M. C., Jiang, Y., Li, Y., Li, F., Mitchell, T., Mallem, M. R., et al. (2011) · mAbs · doi:10.4161/mabs.3.3.15532 · Cited by 107
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.